Placebo-controlled Trial of Nimodipine in the Treatment of Acute Ischemic Cerebral Infarction.
Completed
Phase N/A ResultsSummary of Purpose
To assess the effects of oral nimodipine on the mortality rate and neurologic outcome of patients with an acute ischemic stroke.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 14 September 2000.
Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Design
Double-blind, placebo-controlled, multicenter trial involving 164 patients.
Contacts
Not available
Recruitment
- Gender: Both
- Study Size: 164
- Max Time from Onset: 48 Hours
- Follow Up: 28 Days
Principal Investigator
- E Martinez-Vila